Two FTO inhibitors, FB23 and FB23-2, can attenuate the activity of FTO demethylase by directly binding to the activity pocket of FTO demethylase, resulting in a significant lethal effect on cancer cells [138]. This evidence concerns the gene FTO and cancer.